Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Qing

Showing results (401-410 of 411) with videos related to

Pageof 42
Sort By:
Journal of Hematology & Oncology|February 2, 2024
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translationMeilin Xue, Lei Dong, Honghai Zhang, et al.
Cell Stem Cell|August 4, 2023
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewalYangchan Li, Meilin Xue, Xiaolan Deng, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 1, 2020
2019 Chinese Hypertension League guidelines on home blood pressure monitoringJi-Guang Wang, Pei-Li Bu, Lu-Yuan Chen, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Cancer Cell|June 13, 2020
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune EvasionRui Su, Lei Dong, Yangchan Li, et al.
Nature|March 15, 2019
Histone H3 trimethylation at lysine 36 guides m<sup>6</sup>A RNA modification co-transcriptionallyHuilin Huang, Hengyou Weng, Keren Zhou, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
Journal of the American Society for Mass Spectrometry|March 12, 2021
New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory StudyTrina Mouchahoir, John E Schiel, Rich Rogers, et al.
Journal of the American Society for Mass Spectrometry|August 26, 2022
Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory StudyTrina Mouchahoir, John E Schiel, Rich Rogers, et al.
Pageof 42

Showing results (401-410 of 411) with videos related to

Sort By:
Pageof 42
Journal of Hematology & Oncology|February 2, 2024
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translationMeilin Xue, Lei Dong, Honghai Zhang, et al.
Cell Stem Cell|August 4, 2023
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewalYangchan Li, Meilin Xue, Xiaolan Deng, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 1, 2020
2019 Chinese Hypertension League guidelines on home blood pressure monitoringJi-Guang Wang, Pei-Li Bu, Lu-Yuan Chen, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Cancer Cell|June 13, 2020
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune EvasionRui Su, Lei Dong, Yangchan Li, et al.
Nature|March 15, 2019
Histone H3 trimethylation at lysine 36 guides m<sup>6</sup>A RNA modification co-transcriptionallyHuilin Huang, Hengyou Weng, Keren Zhou, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
Journal of the American Society for Mass Spectrometry|March 12, 2021
New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory StudyTrina Mouchahoir, John E Schiel, Rich Rogers, et al.
Journal of the American Society for Mass Spectrometry|August 26, 2022
Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory StudyTrina Mouchahoir, John E Schiel, Rich Rogers, et al.
Pageof 42